Le Lézard
Classified in: Health
Subjects: LEG, AVO

Interview Availability: Advisory Council on the Implementation of National Pharmacare


OTTAWA, June 12, 2019 /CNW/ - John Adams, Chair of the Best Medicines Coalition (BMC), is available to offer comment on the final report of the Advisory Council on the Implementation of National Pharmacare, set to be released today. The BMC is a national alliance of 30 patient organizations.

The coalition and its members were active participants throughout the Advisory Council's consultation process and are in strong agreement that the current system of pharmaceutical care is inadequate to meet the needs of many patients. The coalition's submission to the Advisory Council urged leaders to prioritize addressing the most critical disparities and inequities in the system stressing that all patients, without exception, must be able to obtain a comprehensive range of medically-necessary medications. 

John Adams, the BMC's Chair, is available for interviews in Ottawa today. John is a long-time patient advocate. His views are informed by his leadership of the coalition and by personal experiences.

About the Best Medicines Coalition
The Best Medicines Coalition is a national alliance of 30 patient organizations with a shared goal of equitable and consistent access for all Canadians to safe and effective medicines that improve patient outcomes. The BMC's areas of interest include drug approval, assessment and reimbursement, as well as patient safety and supply issues. As an important aspect of its work, the BMC strives to ensure that Canadian patients have a voice and are meaningful participants in health policy development, specifically regarding pharmaceutical care.

SOURCE Best Medicines Coalition


These press releases may also interest you

at 11:16
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...

at 11:10
Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As...

at 11:09
ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...

at 11:05
With a goal to better inform health care workers about weapons of mass destruction, the Emergency Nurses Association and FBI recently partnered to launch the Bureau's "ABCs on WMDs" podcast series on the association's website....

at 11:00
Emperion is proud to announce the appointment of Matt Padden as the newest addition to its leadership team. With a proven track record of driving sales growth and cultivating strong client relationships, Padden brings a wealth of experience and...



News published on and distributed by: